These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4698717)

  • 1. [Antiparkinsonism drug (Parkan) as a hallucinogen].
    Kisszékelyi O
    Orv Hetil; 1973 Apr; 114(15):855-9. PubMed ID: 4698717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trihexyphenidyl (Parkan) as hallucinogen].
    Kuncz E; Liziczai E
    Orv Hetil; 1973 Nov; 114(45):2732-3. PubMed ID: 4753045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Artane--a narcotic drug?].
    Ott B; Jura I
    Nervenarzt; 1972 Apr; 43(4):216-7. PubMed ID: 5047931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hallucinosis due to trihexyphenidyl abuse].
    Palao DJ; Araúxo A; Bernardo M
    Med Clin (Barc); 1991 Jul; 97(6):239. PubMed ID: 1943290
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fatal poisoning caused by a hallucinogen (glue)].
    Kenyeres I; Somogyi E; Bellus E
    Orv Hetil; 1974 Aug; 115(32):1874-6. PubMed ID: 4845555
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxicomaniac behavior caused by artane].
    Gonin D; Védrinne J; Vincent V; Jouglard J; Faivre M
    Med Leg Dommage Corpor; 1971; 4(2):149-51. PubMed ID: 5109562
    [No Abstract]   [Full Text] [Related]  

  • 7. [Can we speak of trihexyphenidyl toxicomania?].
    Gayral L; Moron P; Escande M; Curie-Seimbres P
    Ann Med Psychol (Paris); 1971 Oct; 2(3):419-23. PubMed ID: 5128634
    [No Abstract]   [Full Text] [Related]  

  • 8. Benzhexol-induced hallucinosis.
    Hussain MZ
    Can Med Assoc J; 1971 Mar; 104(5):420-1. PubMed ID: 5557919
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug abuse: legal and ethical implications of the non-medicinal use of hallucinogenic and narcotic drugs. The Mary Scott Newbold symposium.
    Wood FC; Elkinton JR
    Trans Stud Coll Physicians Phila; 1968 Oct; 36(2):63-95. PubMed ID: 5693203
    [No Abstract]   [Full Text] [Related]  

  • 10. [A method for the prevention of drug abuse].
    Párkányi L
    Orv Hetil; 1970 Aug; 111(31):1855. PubMed ID: 5466175
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems of hallucinogen dependance].
    Radouco-Thomas S
    Laval Med; 1969 Jan; 40(1):59-65. PubMed ID: 5774373
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polypragmasy and the criminal law].
    Dezsö L
    Orv Hetil; 1971 May; 112(19):1190-2. PubMed ID: 5088634
    [No Abstract]   [Full Text] [Related]  

  • 13. Human hallucinogenic drug research: regulatory, clinical, and scientific issues.
    Strassman RJ
    NIDA Res Monogr; 1994; 146():92-123. PubMed ID: 8742796
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs and drugged behavior: medicolegal considerations.
    Cohen S
    J Clin Pharmacol J New Drugs; 1969; 9(1):5-11. PubMed ID: 5250313
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new hallucinogen ("STP")].
    Retterstol N
    Tidsskr Nor Laegeforen; 1969 Nov; 89(21):1657. PubMed ID: 5407946
    [No Abstract]   [Full Text] [Related]  

  • 16. Abuse of antiparkinsonism drugs. Feigning of extrapyramidal symptoms to obtain trihexyphenidyl.
    Rubinstein JS
    JAMA; 1978 Jun; 239(22):2365-6. PubMed ID: 642176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents.
    Chung T; Martin CS
    J Consult Clin Psychol; 2005 Dec; 73(6):995-1004. PubMed ID: 16392973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].
    Thomasius R; Gouzoulis-Mayfrank E; Karus C; Wiedenmann H; Hermle L; Sack PM; Zeichner D; Küstner U; Schindler A; Krüger A; Uhlmann S; Petersen KU; Zapletalova P; Wartberg L; Schütz CG; Schulte-Markwort M; Obrocki J; Heinz A; Schmoldt A;
    Fortschr Neurol Psychiatr; 2004 Dec; 72(12):679-95. PubMed ID: 15580533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug addiction, toxicomania. Viewpoints on establishing new measures of control].
    Bertschinger P
    Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):96-103. PubMed ID: 5141146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.